{"nctId":"NCT00608322","briefTitle":"Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis","startDateStruct":{"date":"2009-08"},"conditions":["Sepsis"],"count":49,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Inhaled nitric oxide"]},{"label":"2","type":"SHAM_COMPARATOR","interventionNames":["Other: Sham inhaled nitric oxide"]}],"interventions":[{"name":"Inhaled nitric oxide","otherNames":["INOmax"]},{"name":"Sham inhaled nitric oxide","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Confirmed or suspected infection (acute)\n\n   PLUS:\n2. One or both of the following criteria for potential tissue hypoperfusion:\n\n(2a) systolic blood pressure \\<90 mmHg despite 30cc/kg intravenous crystalloid challenge, OR (2b) serum lactate \\>4 mmol/L.\n\nExclusion Criteria:\n\n1. age \\< 14 years\n2. pregnancy\n3. \"Do Not Resuscitate\" status (prior to enrollment)\n4. active clinically significant bleeding of any etiology\n5. status-post cardiac arrest\n6. need for immediate surgery\n7. inability to place a sublingual videomicroscopy probe under the tongue (e.g. inability to open the mouth or patient requirement of a high-flow face mask for supplemental oxygen \\[although videomicroscopy can be performed in patients with an endotracheal tube or nasal cannula\\])\n8. \\>24 hours elapsed since first documented evidence of meeting criteria for potential tissue hypoperfusion (2a or 2b above).\n9. inability to obtain written informed consent","healthyVolunteers":false,"sex":"ALL","minimumAge":"14 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in the Sequential Organ Failure Assessment (SOFA) Score","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"PRIMARY","title":"Change in Sublingual Microcirculatory Flow Index (MFI)","description":"The MFI is a continuous scale from 0-3, with 3.0 being better outcome and 0.0 being worse outcome.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.06","spread":null},{"groupId":"OG001","value":"-0.03","spread":null}]}]}]},{"type":"SECONDARY","title":"Lactate Clearance (Blood)","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":26},"commonTop":["Death"]}}}